MDGL
MADRIGAL PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$399.63
+0.84%Forward multiples
Based on analyst estimates
- P/E forward
- 207.40x
- P/E 2026E
- —
- P/E 2027E
- 65.14x
- P/E 2028E
- 17.90x
- P/S forward
- 4.74x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 14.81x
- Price / sales
- 6.50x
- Price / cash flow
- -59.13x
Enterprise value
- Enterprise value
- $8.7B
- EV / sales
- 6.08x
- EV / EBITDA
- -71.24x
- EV / EBIT
- -56.84x
- Market cap
- $9.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026